Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicenter Study to Evaluate the Safety/Efficacy of APC-111 MP Tablet QD vs. Penicillin VK QID Both for 10 Days Treatment of Pharyngitis Secondary to S.Pyogenes in Adolescents/Adults

NCT00242281 is registered in ClinicalTrials.gov with Advancis Pharmaceutical Corporation as lead sponsor.

NCT NCT00242281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicenter Study to Evaluate the Safety/Efficacy of APC-111 MP Tablet QD vs. Penicillin VK QID Both for 10 Days Treatment of Pharyngitis Secondary to S.Pyogenes in Adolescents/Adults
Lead sponsor
Advancis Pharmaceutical Corporation
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2005
Completion date
July 31, 2006
Enrollment
600
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

pharyngitis, sore throat, tonsillitis